LAVA Therapeutics NV

NASDAQ:LVTX   3:59:41 PM EDT
10.93
-0.37 (-3.27%)
Other Pre-Announcement

LAVA Therapeutics NV Q1 Loss Per Share EUR 10.19

Published: 05/20/2021 10:44 GMT
LAVA Therapeutics NV (LVTX) - Lava Therapeutics Provides Business Update and Reports First Quarter Financial Results.
Q1 Loss per Share EUR 10.19.
Cash and Cash Equivalents Expected to Fund Operations at Least Into Second Half of 2023.
Net Loss Was EUR 16.6 Million, Or EUR 10.19 per Share, for Q1 of 2021.
Clinical Development Plans on Schedule in Both Hematological and Solid Tumor Programs.